Table 5. Cumulative content of salidroside and p-tyrosol in urinary samples following i.v. and i.g. administration of salidroside (i.v. 50 mg/kg, i.g. 100 mg/kg) (n = 6).

Time (h)	i.v. administration (µg)		i.g. administration (µg)
	Salidroside	p-tyrosol	Salidroside	p-tyrosol
0–12	6704.77±494.55	2.60±0.14	3698.97±649.45	3.64±0.08
12–24	501.45±65.03	5.60±0.90	638.13±117.12	22.04±0.75
24–48	521.55±65.83	2.39±0.35	Nd	327.25±121.05
48–72	272.27±20.78	0.27±0.03	Nd	85.06±19.11
0–72	8000.06±519.38	10.86±0.43	4337.10±766.43	407.10±37.08
Excretion (% of dose)	64.00±4.15	0.19±0.01	23.80±3.32	2.25±0.28

Nd: not detectable.